top of page
HOME

Advancing the next generation of antiviral therapies

Our
Mission

At Via Nova Therapeutics, our mission is to discover novel therapies for viral diseases, especially those arising from acute and subacute infections, and to efficiently bring these treatments to the clinic.

Via Nova Therapeutics Influenza Virus
Via Nova adenovirus_edited.png
Via Nova BK Polyomavirus

Who
We Are

Via Nova is Latin for New Road.

The name reflects

(i) our plan to diverge from the established industry path, which is focused on chronic viral infections, and focus instead on acute and subacute infections; and

(ii) our belief that new, rapid at-home and point-of care diagnostics for these infections creates new opportunities to bring their treatments to the clinic.

Via Nova Rhinovirus

OUR FOCUS

We believe that the next frontier of unmet medical need in virology exists among the acute and subacute viral infections.

OUR SCIENCE

Our team employs state-of-the-art drug discovery modalities to identify novel, first-in-class antivirals.

OUR PIPELINE

We are committed to advancing our pipeline of first-in-class antivirals with additional discovery efforts to follow.

bottom of page